LMED同业对比
LMED 与SIC 7370 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LMED本股 | — | — | — | — | — | 93.6%#4 | — | -2.9%#7 | — | — | — | — |
| JF | — | — | — | — | — | 38.4%#7 | -83.9%#8 | -88.9%#9 | — | — | — | — |
| JG | — | — | — | — | 23.7%#2 | 106.3%#3 | 0.2%#5 | 0.6%#5 | 0.5%#3 | — | — | — |
| KNRX | $10M#8 | — | — | 1.6x#4 | -44.2%#10 | -96.2%#12 | -155.5%#10 | — | — | — | — | — |
| LAWR | $172M#6 | — | — | — | — | — | — | — | — | — | 82.0%#3 | — |
| LCFY | $4M#10 | — | — | — | — | — | — | — | — | — | -64.3%#6 | — |
| LCFYW | $119M#7 | — | — | — | — | — | — | — | — | — | 716.5%#1 | — |
| LGCL | $9M#9 | 45.7x#3 | 0.2x#1 | 0.1x#1 | 2.3%#6 | -74.3%#10 | 1.9%#4 | 3.1%#3 | 4.1%#2 | — | -99.5%#7 | — |
| META | $1.72T#1 | 25.5x#2 | 6.6x#4 | 8.6x#6 | 22.2%#3 | -3.1%#8 | 41.4%#1 | 23.1%#1 | 17.8%#1 | — | -12.3%#4 | 0.3%#1 |
| MITI | — | — | — | — | -11.4%#9 | 119.9%#1 | -4852.8%#11 | — | — | — | — | — |
| NBIS | $54.1B#2 | 648.2x#5 | 11.8x#5 | 102.2x#7 | 479.0%#1 | 112.9%#2 | -115.5%#9 | 1.8%#4 | -8.6%#5 | — | 127.4%#2 | — |
| NEXN | $510M#5 | — | — | 1.4x#3 | -0.2%#7 | -29.3%#9 | 8.9%#2 | — | — | — | — | — |
| NXDR | — | — | — | — | 4.2%#5 | 44.7%#6 | -27.9%#7 | -13.2%#8 | — | — | — | — |
| PINS | $11.0B#3 | 54.0x#4 | 3.8x#3 | 2.6x#5 | 15.8%#4 | -77.6%#11 | 7.6%#3 | 14.4%#2 | — | — | -49.6%#5 | — |
| PPLI | $2.8B#4 | 8.5x#1 | 0.6x#2 | 1.2x#2 | -8.7%#8 | 80.7%#5 | -4.1%#6 | -2.0%#6 | -1.8%#4 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议